Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
What Is The Long Term Average Annual Return For Index Funds
Learn the long-term average annual return for index funds and how it informs portfolio construction, diversification, and risk management.
27,739 articlesHockey Might Coming Houston: Friedkin-NHL Talks in Texas
The NHL is evaluating a Texas expansion with Dan Friedkin, potentially in Houston or Austin. A six-month term sheet o...
Only Fully Integrated U.S. Rare Earth Plays for Investors
MP Materials is capturing attention as the only fully integrated u.s. rare earth producer. With buzz around potential...
Steve Ballmer Just Received a Massive Dividend Payday
Microsoft's latest quarterly dividend yields a nine-figure payment to Steve Ballmer, illustrating the power of long-t...
Nuclear Energy Story 2026: 3 Stocks to Own All Year
The nuclear energy story 2026 is taking shape as decarbonization and power-hungry data demand push expansion. This gu...
Richard Hammond Seen with: What It Means for Your Finances
When headlines shout about who a beloved celebrity is dating, it’s easy to miss the money lessons behind the gossip. ...
This Small-Cap Manager Just Sold Its Stake, Investors
When a notable small-cap manager exits a large stake in a data-security firm, it creates questions for investors. Thi...
After Drop, CoreWeave Stock: Buy on the Dip or Avoid?
After an 11% drop, investors wonder if CoreWeave stock can rebound. This article weighs the bull and bear cases, what...
Home Depot Price Targets Slashed After Q1 Results
Analysts trimmed Home Depot price targets after the retailer's Q1 results, signaling a cyclical pause rather than a l...
Micron’s Sell-Off Gift as AI Memory Shortage Looms
Micron’s shares fell about 12% at the open amid a broad market rout. Yet analysts see a longer-term memory shortage d...
CoreWeave Price Prediction: The Case for 70% Upside
CoreWeave stock moves in a volatile path as a growing backlog and AI partnerships underpin a potential upside. This a...
Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status